Clinical trials
Phase 3 Urinary Bladder Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
| Completed | 7 |
| Recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Asan Medical Center | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Janssen Research & Development, LLC | 2 |
| Pfizer | 2 |
| Bristol-Myers Squibb | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 22 |
| Carcinoma, Transitional Cell | 9 |
| Ureteral Neoplasms | 3 |
| Urethral Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Carcinoma | 1 |
| Female Urogenital Diseases | 1 |
| Male Urogenital Diseases | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.